10X Genomics Inc vs Energy Select Sector SPDR Fund — how do they compare? 10X Genomics Inc trades at $83.55 (market cap $10.07B), while Energy Select Sector SPDR Fund trades at $65.6 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 4.1× 10X Genomics Inc's market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, 10X Genomics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| TXG | XLE | |
|---|---|---|
Market Cap | $10.07B | $40.84B |
Volume | 5,657,286 | 50,409,268 |
Sector | Health | — |
52-Week High | $97.74 | $65.93 |
52-Week Low | $11.48 | $42.61 |
Typical Hold Time | 92 Days | 67 Days |
Enterprise Value | $9.59B | — |
Signals from Pluang's Aura AI — not financial advice
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
XLE (Energy Select Sector SPDR ETF) trades at $65.46, up 3.28% with strong bullish momentum from moving averages but overbought RSI signals. The ETF faces mixed sentiment as oil prices surge above $100 amid Middle East tensions while futures traders bet on a 12% energy sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures, creating volatility in energy markets.
Outlook remains volatile with geopolitical risks and Fed policy influencing energy prices. The ETF's 91% oil and gas concentration offers pure energy exposure but amplifies crude price sensitivity. Key risks include oil price reversals and export restrictions, while institutional flows into midstream ETFs suggest defensive positioning within the sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →